Financial Summary (All financials)
| In millions, except per share items | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 |
| Revenues | 46.1 | 18.3 | 26.7 | 51.4 |
| Revenue growth | 152.4% | -31.6% | -48.1% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 46.1 | 18.3 | 26.7 | 51.4 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 122.2 | 151.3 | 195.1 | 200.7 |
| General and administrative | 38.1 | 46.3 | 45.0 | 36.6 |
| EBITA | -114.2 | -177.7 | -211.8 | -184.1 |
| EBITA margin | -247.6% | -973.0% | -793.6% | -358.0% |
| Amortization of intangibles | | 1.6 | 1.6 | 1.8 |
| EBIT | -114.2 | -179.4 | -213.5 | -185.9 |
| EBIT margin | -247.6% | -982.1% | -799.8% | -361.5% |
| Pre-tax income | -141.7 | -161.7 | -227.2 | -186.6 |
| Income taxes | 0.0 | 0.1 | 0.1 | 0.1 |
| Tax rate | 0.0% | | | |
| Net income | -141.7 | -161.8 | -227.3 | -186.7 |
| Net margin | -307.3% | -886.0% | -851.6% | -363.1% |
| |
| Diluted EPS | ($5.90) | $0.00 | $0.00 | $0.00 |
| Shares outstanding (diluted) | 24.0 | 23.9 | 23.9 | 23.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|